Member Info for andmillsy

General negative on miners weighing down performance with BHP, Rio Tinto etc all down. I suspect that will hold us back a bit today but as holding and waiting RNS it doesn't really matter.

Hillarious ! :)

I am considering investing here as have felt strong future for Hydrogen and government commitment appeared strong.
Its worth looking at all sides of the discussion about hydrogen and in todays ft the following article questions adoption of hydrogen for transport. May be worth a look. If you are not a subscriber to ft then I think you can access one article for free but if you have used your freebie then using the link in an incognitio / private browsing window may give you access ...
https://www.ft.com/content/a1325d48-6c76-4b6f-81e8-2be504c21791

This has been on strong rise last few weeks - much appreciated !
There is not imho a lot of news to substantiate the rise - change in CEO but successor not announced, focus on zap map but not sure how this is monetised.
Any perspective on where this can go ?
Thanks

NT to buy as you say even for £1k. Didn't this behavior of NT into the close also happen when RNS dropped on 1 Mar after market closed?

Good question Shorn. Think it might have been 18 Dec - which if correct may mean we have longer to wait.

ASX relevant (I think) announcment
https://investors.alkane.com.au/site/PDF/6478d457-c6b9-4046-8737-a4c240ee94d4/HighGradeZonesatBodaShownbyRevisedDrillOrientation

Keep drilling or as Yoda would say "Judge me by my size, do you?"

Thanks guys for sharing your view. Clearly big upside yet but significant risk. I'll adopt (my usual) wait and watch pattern.
Cheers

Anyone tried to do a compare of the two?
MCAP of CARD about 1/5th of MoonPig.
CARD pre covid financial results are c33% greater revenue. Looking at PBT CARD not as strong as Moonpig see below but it was a profitable business and with strategy to improve margins (price, store rationalisation)

Risks for CARD:
1. Can't get deals with lenders but it is a profitable business so debt / equity swap likely
2. Can they recapture (much of) the market they had pre-covid - customer behaviour back to store shopping. Can small packed stores meet covid secure expectations.
3. Can they make the continue the shift to online

Moonpig
MCAP £1408M
Rev to 30 Apr 21 £340M (margin in line with 2020 therefore c62M)
YE20 (Rev 173M, GP 93M, PBT 32M)

CARD
MCap £229M
YE20 (Rev 451M, PBT 65M) 19M of Revenue from online

Really just a reaction to CBX but even there if you were in IPO offer price you are in the money.
Interesting article on overall cannabis market investment potential https://www.sharesmagazine.co.uk/news/shares/investors-race-to-own-shares-in-cannabis-related-companies-and-funds

Might help the NT situation on the buy if he sells ...

Based on some of the recent performance of companies in that area it could be a quick way to get the share price down to 1.5p ! None the less a very interesting idea.

I've followed TLOU for a couple of years. Having been to South Africa and Botswana a few times the energy challenges are clear and having had some involvement with Arrow Energy after they were acquired by Shell it was clear that TLOU leadership had vision and experience to increase probability of success.
I appear to have been fortunate with timing my small investment in TLOU earlier this year at 3.3p. Really just lucky timing. Whilst the gains are tempting to lock in I believe this may have much more potential but I am finding it extremely difficult to determine a future potential value for the company from the info on their website etc.
Would any of you be willing to share any data / insights on what this company could be worth if it is successful in getting Lesedi up and running, which I appreciate still has some ways to go.
Sorry for the novice question but appreciate any views from those who have more knowledge and insight.
Thanks

Cygnus
Thanks so much for taking the time to share your thoughts and insights in such a clear logical post. Very very useful and definitely I'll be holding this as the market still hasn't priced in the available information or is applying an arguably excessive risk factor. I know it's not guaranteed but downside on sp is very limited and upside significant.
I keep saying that's me done with topping up but looks like I should think again.
Thanks also Andrew, Iceberg and others for all the info you've been kindly sharing.

Thats really helpful thanks Andrew.
I was trying to work this out last night looking at AIM admission statement and RNS for funding but didn't really conclude it. This provides some insight on some of the warrants and given the 1.85p price I think it excludes those warrants which were converted and shares sold.
https://xtractresources.com/investors/rns/funding-facility/

Another "last" top up Docit ? :)

MrTrotter - not sure in all honesty as certainly no expert and not sure if issue price is the same as the exercise price but I used this:
https://www.educba.com/dilution-formula/
Further, the formula for diluted share price can be expressed as a weighted average of a number of existing and new shares as shown below.

Diluted Share Price = (PT * NT + PN * NN) / (NT + NN)
where,
NT = Total Number of Existing Shares
NN = Total Number of New Shares
PT = Current price of existing shares
PN = Issue price of new shares

Did the same calculation Steve
XTR was 735M@ 8p = 58.8
New Equity 5M @ 1.85p = 0.0925
740M mcap s/be 58.8925 or 7.9594p per share ?

After 30 mins got a relatively paltry 25,000 at 7.575 (yay) on Fidelity. I think I said earlier I had stopped buying (Docit) but didn't expect this gift :)

NT NT NT on Fidelity :(